Cambridge-based TidalSense raises €16.6 million in a funding round led by Cross-Border Impact Ventures to accelerate global commercialisation of its AI respiratory diagnostic technology.
TidalSense announced a €16.6 million funding round to support the globalisation of its AI-powered respiratory diagnostic technology. This round included new investor Cross-Border Impact Ventures and returning investors BGF, Airstream Capital, and Foresight Group. The funding will help accelerate the company's commercialisation efforts in the UK and beyond. Founded in 2013, TidalSense aims to improve respiratory diagnostics through innovative sensor technology.
Company Information
Company
TidalSense
Location
Cambridge, England, United Kingdom
About
TidalSense is an AI-powered respiratory diagnostic company that develops innovative solutions to improve the diagnosis and monitoring of respiratory diseases. Founded in 2013, the company is known for its patented sensor technology, N-Tidal, which allows for a non-invasive approach to detecting COPD. With a focus on accessibility, TidalSense aims to address the challenges faced by healthcare professionals and patients in the diagnosis of respiratory conditions. The company is committed to making its technology available globally, starting with the UK and expanding to other markets.
Fundz sees it the moment TidalSense raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
CambridgeBiotechnologyHealth CareArtificial IntelligenceMedicalMedical DeviceHealth Diagnostics